Cargando…
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346231/ https://www.ncbi.nlm.nih.gov/pubmed/35936692 http://dx.doi.org/10.3389/fonc.2022.970623 |
_version_ | 1784761605656936448 |
---|---|
author | Zhang, Jianying Guo, Xiangqian Jin, Bilian Zhu, Qing |
author_facet | Zhang, Jianying Guo, Xiangqian Jin, Bilian Zhu, Qing |
author_sort | Zhang, Jianying |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9346231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93462312022-08-04 Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization Zhang, Jianying Guo, Xiangqian Jin, Bilian Zhu, Qing Front Oncol Oncology Frontiers Media S.A. 2022-07-20 /pmc/articles/PMC9346231/ /pubmed/35936692 http://dx.doi.org/10.3389/fonc.2022.970623 Text en Copyright © 2022 Zhang, Guo, Jin and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhang, Jianying Guo, Xiangqian Jin, Bilian Zhu, Qing Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title | Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title_full | Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title_fullStr | Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title_full_unstemmed | Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title_short | Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
title_sort | editorial: tumor-associated antigens and their autoantibodies, from discovering to clinical utilization |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346231/ https://www.ncbi.nlm.nih.gov/pubmed/35936692 http://dx.doi.org/10.3389/fonc.2022.970623 |
work_keys_str_mv | AT zhangjianying editorialtumorassociatedantigensandtheirautoantibodiesfromdiscoveringtoclinicalutilization AT guoxiangqian editorialtumorassociatedantigensandtheirautoantibodiesfromdiscoveringtoclinicalutilization AT jinbilian editorialtumorassociatedantigensandtheirautoantibodiesfromdiscoveringtoclinicalutilization AT zhuqing editorialtumorassociatedantigensandtheirautoantibodiesfromdiscoveringtoclinicalutilization |